09:53AM 11/23/09
Paulson's Big Trade, Bearish Bets and Biotech
Guests include Gregory Zuckerman, author of 'The Greatest Trade Ever', Steven Lehman, portfolio manager for the Federated Market Opportunity fund and Adam Feuerstein, TheStreet.com's biotech reporter.
04:40PM 11/11/09
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
12:16PM 11/10/09
Bristol Licenses Arthritis Drug: BioBuzz
Worldwide deal involves privately held Alder BioTherapeutics
09:20AM 11/10/09
Celgene in ASH Abstract Spotlight: BioBuzz
A blood cancer meeting also is important for Onyx, Cephalon and Ariad.
06:31AM 11/10/09
Pelosi Can't Kill the Health Care Sector (RealMoney.com $)
The Senate is filled with more-savvy politicians, and the upside for beaten-down names is huge.
08:33AM 11/09/09
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Cisco, Tessera and ImmunoGen.
08:06AM 11/05/09
Cramer's 'Mad Money' Follow-Up: Nov. 4
Here's how some of Tuesday's 'Mad Money' stocks fared on Wednesday.
05:24PM 11/04/09
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Celgene, Research In Motion and Berkshire Hathaway.
08:26AM 11/04/09
Cramer's 'Mad Money' Recap: The Only Sectors That Matter (Final)
Cramer says the market won't rally until oil, bank and tech stocks rebound. Click for news from Jim Cramer.
06:35PM 11/03/09
Spo Advisory Buys $9.5M Worth of Resolute Energy
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
11:52AM 10/30/09
The Bull and Bear Story on GTx's Pending Drug Decision: BioBuzz
Acapodene faces an FDA decision Friday.
10:56AM 10/27/09
Big-Cap Biotech Worries Lead Sector Down: BioBuzz
Getting answers to why biotech is underperforming.
07:37AM 10/27/09
Celgene 3Q Profit Surges On Cancer Drug Sales
Celgene's 3rd-quarter profit jumps 58 percent on cancer drug sales, tops forecasts
11:01AM 10/22/09
'Mad Money Lightning Round': Stick With Celgene
Cramer says the stock has made a lot of money.
07:33PM 10/13/09



Connect with TheStreet